Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 550 Broad Street
  • Suite 1212
  • Newark, NJ 07102

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2015 10-Q
CIK 0000072170
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2000
Employees 11 a/o Dec 31, 2014
Company Officers/Contacts
Michael C. James CEO, CFO
James Kras COO, IR, President
Company Directors
Michael C. James Chairman
James Delucia
James Kras
Service Providers
Accounting/Auditing Firm
Friedman LLP
301 Lippincott Drive
4th Floor
Marlton, NJ, 08053
United States
Securities Counsel
Silverman Shin Byrne & Gilchrest
381 Park Avenue
New York, NY, 10016
United States
Investor Relations Firm
KARV Communications
590 Madison Avenue
New York, NY, 10022
United States
Company History
  • Formerly=Millennium Biotechnologies Group, Inc. until 5-2010
  • Formerly=Regent Group, Inc. until 4-02
  • Formerly=NMC Corp. until 9-97
NRTI Security Details
Share Structure
Market Value1 $195,860 a/o Jun 22, 2017
Authorized Shares 2,000,000,000 a/o Jun 14, 2017
Outstanding Shares 1,958,595,468 a/o Jun 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 561 a/o Apr 15, 2015
Short Selling Data
Short Interest 669 (0%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security